Amicus Therapeutics Highlights Data Featured at Lysosomal Disease Network WORLD Symposium 2014

[GlobeNewswire] – First Scientific Meeting to Present Preclinical Proof-of-Concept Data for Next-Generation Pompe ERT and Proprietary Enzyme Targeting Technology more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view